Richard B. Borgens,Riyi Shi,Stephen R. Byrn,Daniel T. Smith
申请号：
US12878495
公开号：
US08729107B2
申请日:
2010.09.09
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Embodiments of the present disclosure provide a novel pyridine, pharmaceutical compositions comprising such pyridine, and the use of such compositions in treating injured mammalian nerve tissue, including but not limited to an injured spinal cord. In at least one embodiment of the method, the method comprises the step of administering to the mammal in need thereof with a pharmaceutical composition, or pharmaceutically acceptable salt, comprising 4-aminopyridine-3-methanol.
